Calendar Citius Pharmaceuticals, Inc.

Equities

CTXR

US17322U2078

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT Pre-market 07:03:21 am
0.6648 USD -9.25% Intraday chart for Citius Pharmaceuticals, Inc. 0.675 +1.53%

Chart calendar Citius Pharmaceuticals, Inc.

e3b86a9d.J2yVRGrfiTPOoI09uSo1D2C7OtNC4lJVscFGZ_hmBCM.TxnFCRyG4nCf785rwEVeQCHPfqY6ljgzg6oQUdVfUVJIG6w1LObgQK-Q-g~da877730731e2f636ed8064b582c697c

Upcoming events on Citius Pharmaceuticals, Inc.

2024-08-07 Q3 2024 Earnings Release (Projected)
2025-02-06 Q1 2025 Earnings Release (Projected)
2025-12-09 Q4 2024 Earnings Release (Projected)
2026-02-05 Q1 2026 Earnings Release (Projected)

Past events on Citius Pharmaceuticals, Inc.

2024-04-17 10:30 am Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
2024-04-09 03:30 pm LD Micro Invitational Conference
2024-03-13 01:45 pm Sidoti Small Cap Conference
2024-03-12 08:00 am Annual General Meeting
2024-02-27 09:45 am BIO CEO & Investor Conference
2024-02-14 04:30 pm Q1 2024 Earnings Release
2024-01-02 08:30 am Q4 2023 Earnings Release
2023-12-04 12:00 am Noble Capital Markets Emerging Growth Equity Conference
2023-11-28 GCFF Virtual Healthcare Conference
2023-11-15 11:30 am Sidoti Microcap Virtual Conference
2023-10-19 02:30 pm ThinkEquity Conference
2023-10-12 01:30 pm Dawson James Small Cap Growth Conference
2023-09-20 02:30 pm Sidoti Small Cap Conference
2023-09-11 02:00 pm H.C. Wainwright Global Investment Conference
2023-08-14 04:15 pm Q3 2023 Earnings Release
2023-06-21 01:00 pm Maxim Group Virtual Healthcare Conference
2023-03-11 Roth Conference
2023-02-10 04:30 pm Q1 2023 Earnings Release
2023-02-06 Annual General Meeting
2023-01-18 10:45 am Sidoti Micro-Cap Virtual Conference

Annual results

Fiscal PeriodSeptember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-15,6
-15,9
1.9%
-17,7
-18,8
5.79%
-23,5
-24,9
5.54%
-33,3
-34,5
3.48%
-36,7
-35,6
-3.16%

-36,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-23,1
-24,7
6.57%
-33,1
-34,4
3.8%
-32,0
-31,1
-2.94%

-36,5

Net income
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-24,5
-24,7
0.69%
-33,6
-34,4
2.13%
-33,7
-31,6
-6.53%

-36,6

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-0,23
-0,23
0%
-0,23
-0,24
4.17%
-0,22
-0,21
-4.76%

-0,22

Announcement Date16/12/1916/12/2015/12/2122/12/2229/12/23-

Quarterly results

Fiscal PeriodSeptember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


10,6


11,0

EBIT
Million USD
Released
Forecast
Spread
-9,26
-8,20
-12.92%
-7,59
-10,5
27.89%
-8,92
-8,99
0.77%
-7,55
-8,75
13.74%



-10,7
-7,54
-41.8%
-8,67
-10,7
18.8%
-10,1
-8,95
-13.13%




-8,31


-8,53


-8,73







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-9,23
-8,20
-12.5%
-7,56
-10,5
28.17%
-8,86
-8,99
1.36%
-7,41
-8,72
14.99%



-10,4
-7,49
-38.56%
-8,34
-10,6
21.66%
-9,80
-8,89
-10.28%




-8,31


-8,53


-8,73







Net income
Million USD
Released
Forecast
Spread
-9,23
-8,20
-12.5%
-7,56
-10,5
28.17%
-8,86
-8,99
1.36%
-7,99
-8,72
8.38%
-3,59


-10,5
-7,54
-39.55%
-8,48
-10,7
20.68%
-11,1
-8,97
-23.76%




-8,31


-8,53


-8,73







EPS
USD
Released
Forecast
Spread
-0,06
-0,06
0%
-0,05
-0,07
28.57%
-0,06
-0,06
0%
-0,05
-0,06
16.67%
-0,02


-0,07
-0,05
-40%
-0,06
-0,07
14.29%
-0,07
-0,06
-16.67%
-0,06



-0,06


-0,05


-0,05







Announcement Date10/02/2212/05/2211/08/2222/12/2210/02/2312/05/2314/08/2329/12/2314/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CTXR Stock
  4. Calendar Citius Pharmaceuticals, Inc.